Masand N - Search Results

1

Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents.

Singhal S, Manikrao Patil V, Verma S, Masand N. Singhal S, et al. Among authors: masand n. Bioorg Chem. 2024 May;146:107277. doi: 10.1016/j.bioorg.2024.107277. Epub 2024 Mar 12. Bioorg Chem. 2024. PMID: 38493634 Review.

2

The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma.

Perry TA, Masand N, Vrzalikova K, Pugh M, Wei W, Hollows R, Bouchalova K, Nohtani M, Fennell E, Bouchal J, Kearns P, Murray PG. Perry TA, et al. Among authors: masand n. Cancers (Basel). 2024 Jan 29;16(3):574. doi: 10.3390/cancers16030574. Cancers (Basel). 2024. PMID: 38339325 Free PMC article.

3

Nanotechnology-Based Drug Delivery of Topical Antifungal Agents.

Singh S, Patil VM, Paliwal SK, Masand N. Singh S, et al. Among authors: masand n. Pharm Nanotechnol. 2023 Aug 18. doi: 10.2174/2211738511666230818125031. Online ahead of print. Pharm Nanotechnol. 2023. PMID: 37594096

4

Preclinical to Clinical Profile of Curcuma longa as Antidiabetic Therapeutics.

Kaushik S, Masand N, Iyer MR, Patil VM. Kaushik S, et al. Among authors: masand n. Curr Top Med Chem. 2023;23(24):2267-2276. doi: 10.2174/1568026623666230428101440. Curr Top Med Chem. 2023. PMID: 37132313

5

Prospective mode of action of Ivermectin: SARS-CoV-2.

Patil VM, Verma S, Masand N. Patil VM, et al. Among authors: masand n. Eur J Med Chem Rep. 2022 Apr;4:100018. doi: 10.1016/j.ejmcr.2021.100018. Epub 2021 Nov 22. Eur J Med Chem Rep. 2022. PMID: 36593981 Free PMC article. Review.

6

Protein Informatics and Vaccine Development: Cancer Case Study.

Verma S, Masand N, Cheke RS, Patil VM. Verma S, et al. Among authors: masand n. Curr Top Med Chem. 2022;22(26):2207-2220. doi: 10.2174/1568026623666221107160636. Curr Top Med Chem. 2022. PMID: 36345238

7

Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Gautam V, Gaurav A, Masand N, Lee VS, Patil VM. Gautam V, et al. Among authors: masand n. Mol Divers. 2023 Apr;27(2):959-985. doi: 10.1007/s11030-022-10489-3. Epub 2022 Jul 11. Mol Divers. 2023. PMID: 35819579 Review.

8

Non-cancer to anti-cancer: investigation of human ether-a-go-go-related gene potassium channel inhibitors as potential therapeutics.

Patil VM, Gaurav A, Garg P, Masand N. Patil VM, et al. Among authors: masand n. J Egypt Natl Canc Inst. 2021 Nov 8;33(1):33. doi: 10.1186/s43046-021-00091-3. J Egypt Natl Canc Inst. 2021. PMID: 34746987

9

QSAR Studies to Predict Activity of HSP90 Inhibitors.

Patil VM, Masand N, Gupta SP, Blagg BSJ. Patil VM, et al. Among authors: masand n. Curr Top Med Chem. 2021;21(25):2272-2291. doi: 10.2174/1568026621666211011095858. Curr Top Med Chem. 2021. PMID: 34635040

10

Chromones: Privileged scaffold in anticancer drug discovery.

Patil VM, Masand N, Verma S, Masand V. Patil VM, et al. Among authors: masand n. Chem Biol Drug Des. 2021 Nov;98(5):943-953. doi: 10.1111/cbdd.13951. Epub 2021 Sep 19. Chem Biol Drug Des. 2021. PMID: 34519163 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page